on B.R.A.I.N. Biotechnology Research And Information Network AG (isin : DE0005203947)
BRAIN Biotech AG Announces Merger to Enhance Structural Efficiency
BRAIN Biotech AG has officially declared the merging of its subsidiary AnalytiCon Discovery GmbH into BRAIN Biotech AG, aimed at optimizing the corporate structure. This decision, backed by both the Management Board and the Supervisory Board, is anticipated to simplify operations within the group while maintaining the status quo at operational business levels across both locations.
The Potsdam-based AnalytiCon Discovery GmbH, a wholly-owned entity of BRAIN Biotech, will now operate under the BRAIN Biotech AG banner. Michael Schneiders, CFO of BRAIN Biotech, emphasized that this merger follows last year’s amalgamation of the product divisions and represents a strategic move to consolidate their scientific services within the BioScience business segment. He reassured that this structural modification will not alter the functional dynamics for employees or business partners.
Official documents regarding this merger are accessible on the BRAIN Biotech website, providing stakeholders with detailed insights into the changes and regulatory compliances involved.
R. P.Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all B.R.A.I.N. Biotechnology Research And Information Network AG news